Word: developed
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...While I appreciate the report’s broad contours...it still remains to develop a guiding vision,” said Professor of Slavic Languages and Literatures Julie A. Buckler at the meeting. She later wrote in an e-mail that such a vision is essential in defining “what a good ‘liberal education in the arts and sciences’ should ideally look like today in its diverse individual incarnations...
...highlights of the undergraduate experience both for the essentialness of the material they cover and the superiority of the instruction they offer. The curricular review ends with a note on trust, saying that it hopes to increase “the trust we place in faculty to develop innovative courses” and “the trust we place in students that they will choose wisely.” But for this curricular review to be successful, we must first place our trust in Harvard administrators to organize a framework in which the curriculum can flourish...
...Core put forth in last month’s report on the curricular review, seemed merely incompetent. But administrators were evidently motivated by another, less-than-savory rationale, buried deep within the report in a comma-delineated clause about the Harvard College Courses: “They should develop distinctive course materials for use in, and potentially beyond, Harvard College” (emphasis added). The great secret that explains these new classes, confirmed for me by several people connected to the review, is that administrators indeed hope to “use” these courses “beyond?...
...years--a consequence of their growing girth. "The increase was seen in boys and girls, among whites, African Americans and Mexican Americans," says Paul Muntner, an epidemiologist at Tulane University in New Orleans and the study's lead author. "As these children become adults, they're more likely to develop high blood pressure, heart disease and stroke...
...market migraine, caused largely by expiring patents. There could be more mergers, but Merck, for one, seems to have hit on the less-than-acquisitive solution of partnering with companies that may have a blockbuster in the works. Last month it struck an alliance with Bristol-Myers Squibb to develop and sell an experimental diabetes drug, a joint venture similar to the one Merck formed with Schering-Plough for cholesterol treatments Zetia and Vytorin...